[Correspondence] A new generation of comprehensive precision oncology trials

January, 01, 2024 | Select Oncology Journal Articles

Ian F Tannock’s Comment1 summarises the experience to date in precision medicine for children with cancer2–4 and its parallel with the adult experience. The author states that we should not initiate large trials of precision cancer therapy until further progress in our understanding of paediatric cancer unveils new therapeutic strategies that might improve patient outcomes.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy